Neurovalens receives FDA clearance for medical device to treat anxiety

Neurovalens receives FDA clearance for medical device to treat anxiety

Modius Stress becomes company’s second product cleared for use in US. Neurovalens, a global leader in non-invasive neuro-technology, has received medical device clearance from the US Food & Drug Administration (FDA) to treat anxiety with its Modius Stress device
April 09, 2024 — Craig McConnell
Celebrating Success: Neurovalens Triumphs at Digital DNA Awards 2024

Celebrating Success: Neurovalens Triumphs at Digital DNA Awards 2024

Neurovalens were delighted to be awarded two recognitions at the 2024 Digital DNA awards in Belfast’s ICC, Waterfront on Thursday, March 21st. Small Tech Company of the Year and Highly Commended in the Tech For Good category.  
March 27, 2024 — Craig McConnell
Iain Hendrick (CPO) Joins the Shott Scale Up Accelerator Cohort for 2024

Iain Hendrick (CPO) Joins the Shott Scale Up Accelerator Cohort for 2024

Building a high-performance team requires high performance leadership. Our Chief Project Officer, Iain Hendrick, will be spending the next 12 months on the Shott Scale Up Accelerator program with the Royal Academy of Engineering.
March 26, 2024 — Craig McConnell
Meet The Team - John Conway - Logistics Coordinator

Meet The Team - John Conway - Logistics Coordinator

Joining Neurovalens was a no-brainer for me! I loved the idea of working for a company that was trying to help people. I also had an interest in the brain for as long as I can remember...
March 12, 2024 — Craig McConnell
Meet The Team - Sinead Watson - Head of Clinical & Regulatory

Meet The Team - Sinead Watson - Head of Clinical & Regulatory

My name is Sinead Watson, and I joined Neurovalens in September 2022. My role at Neurovalens is Head of Clinical & Regulatory that involves leading the clinical team in the planning, execution and delivery of several clinical trials and regulatory submissions.
February 07, 2024 — Craig McConnell
UK Innovation at Arab Health

UK Innovation at Arab Health

Neurovalens were delighted to take our FDA Cleared Modius Sleep technology to Arab Health 2024, a Global Healthcare Medical Expo in Dubai from 29th January to 1st February 2024.
February 02, 2024 — Craig McConnell
Meet The Team - Rachel Robinson - Lead Clinical Researcher

Meet The Team - Rachel Robinson - Lead Clinical Researcher

My name is Rachel Robinson and I joined Neurovalens in September 2022 as a Lead Clinical Researcher. From a young age I was always fascinated about the function and development of the human body and this is the main reason I chose to focus my studies within the fields of anatomy and physiology.
January 04, 2024 — Craig McConnell
ISO 13485 Certified Medical Device Company

ISO 13485 Certified Medical Device Company

Neurovalens are an ISO 13485 certified medical device company. This is an international standard that sets out regulatory requirements for medical device quality management systems.
December 04, 2023 — Craig McConnell
Neurovalens at 10 Downing Street

Neurovalens at 10 Downing Street

Our CEO, Jason McKeown was invited back to 10 Downing Street today to discuss our recently FDA cleared treatment for chronic insomnia.
November 27, 2023 — Craig McConnell
Medica 2023

Medica 2023

CPO Iain Hendrick and Software QA Manager Steven George attended Medica 2023 in Düsseldorf, Germany to showcase the newly FDA cleared Modius Sleep headset.
November 24, 2023 — Craig McConnell
Meet The Team - Steven George - Software QA Manager

Meet The Team - Steven George - Software QA Manager

I'm Steven George, but most people know me as Stevie. I've been at Neurovalens almost 6 years, it feels like no time since I joined yet so much has changed and so much has been achieved.
November 22, 2023 — Craig McConnell
Neurovalens receives FDA clearance for medical device to treat insomnia

Neurovalens receives FDA clearance for medical device to treat insomnia

Neurovalens, a global leader in non-invasive neuro-technology, has received medical device clearance from the US Food & Drug Administration (FDA) to treat chronic insomnia with its Modius Sleep device.
October 31, 2023 — Craig McConnell